Stock TT5 XTACY THERAPEUTICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Xtacy Therapeutics Corp. Deutsche Boerse AG

Equities

TT5

CA98423G1072

Market Closed - Deutsche Boerse AG
Other stock markets
 07:07:59 31/05/2024 BST 		5-day change 1st Jan Change
0.0275 EUR +150.00% Intraday chart for Xtacy Therapeutics Corp. +34.15% +120.00%
04-17 Xtacy Therapeutics Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
04-15 Xtacy Therapeutics Corp. Reports Earnings Results for the Full Year Ended September 30, 2023 CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Xtacy Therapeutics Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023
Xtacy Therapeutics Corp. Reports Earnings Results for the Full Year Ended September 30, 2023
Xtacy Therapeutics Corp. Expands MDMA Platform Pharmaceutical Grade Psychedelic Solutions to Solve Unmet Medical Needs
XTACY Therapeutics Announces Debt Settlement
Global Wellness Strategies Inc. will Change its Name to XTACY Therapeutics Corp
Global Wellness Strategies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023
Global Wellness Strategies : Voting Instruction Form (“VIF”) – Annual General Meeting to be held on Wednesday, August 16, 2023
Global Wellness Strategies : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 16, 2023
Global Wellness Strategies : GWS NEWS RELEASE
Global Wellness Strategies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
Global Wellness Strategies Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022
Global Wellness Strategies Inc. Reports Earnings Results for the Full Year Ended September 30, 2022
Global Wellness Strategies Inc. Auditor Raises 'Going Concern' Doubt
Global Wellness Strategies : Files Annual Statements September 2022
Global Wellness Strategies Inc. Announces Formation of Wholly Owned Pharma Subsidiary Focused on Clinical Trials
Global Wellness Strategies Effervescent Cannabis Products Approved to Launch GWS Achieves Major Milestone Partnering with Hempsana Holdings
Global Wellness Strategies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
Global Wellness Strategies Inc. Signs Custom Manufacturing Agreement with Hempsana Holdings
Global Wellness Strategies : Information Circular
Global Wellness Strategies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. XTCY Stock
  4. TT5 Stock
  5. News Xtacy Therapeutics Corp.
  6. Other languages